News | May 13, 2013

New Era in Pediatric Interventional Cardiology Training Needed

Frank Ing spotlights need for new training initiatives to meet challenges, opportunities of the future during SCAI

May 13, 2013 — The impact of pediatric interventional cardiology has never been stronger, nor the need for organized, high-quality training greater, says Frank F. Ing, M.D., FSCAI, who delivered the annual Mullins Lecture at the Society for Cardiovascular Angiography and Interventions (SCAI) 2013 Scientific Sessions. He made the case that advances in technology and growth in the profession mean that now is the time to take training to the next level.

“We’re experiencing a golden era in pediatric interventions,” said Ing, the associate chief of cardiology and director of the cardiac catheterization laboratory at Children’s Hospital Los Angeles. “We’re crossing a threshold that establishes this as a legitimate field that will have a huge impact on pediatric cardiology. As such, we need to start thinking more about how we train the people doing these procedures, to maintain quality and to maintain a movement going forward.”

In his keynote address, Ing focused on the past, present and future of training in pediatric interventional cardiology. Afterward, he co-moderated a panel discussion on fellowship training.

The issue of training in pediatric interventional cardiology is becoming increasingly important these days. Not only have multiple pediatric interventional devices been approved by the U.S. Food and Drug Administration (FDA), but pediatric cardiologists increasingly collaborate with interventionalists specializing in adult structural heart disease and perform hybrid procedures with congenital heart surgeons.

The Mullins Lecture, and the panel discussion afterward, explored the need for guidelines on fellowship training in pediatric interventional cardiology. Scheduled to be published soon, the guidelines are expected to include recommendations on the scope of fellowship training and the minimum number of cases needed to develop expertise in specific pediatric interventional procedures.

“To move forward, you have to maintain a legacy of teaching, of impacting the next generation and their careers and of adding to the science of the field,” he said. “We’ve done it all along, but in a random fashion. Now we have enough critical mass to think hard about organizing official guidelines and some common techniques to training, perhaps using SCAI as a sponsoring umbrella organization.”

 For more information: www.scai.org

Related Content

Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Sponsored Content | Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Medtronic Announces Japanese Regulatory Approval for In.Pact Admiral Drug-Coated Balloon
News | Drug-Eluting Balloons| September 13, 2017
Medtronic plc announced that the In.Pact Admiral Drug-Coated Balloon (DCB) received approval from the Japanese Ministry...
PQ Bypass Reports Positive Results for Detour System in Patients With Long Femoropopliteal Blockages
News | Peripheral Artery Disease (PAD)| September 13, 2017
A subset analysis of the DETOUR I clinical trial showed promising safety and effectiveness results of PQ Bypass’ Detour...
Overlay Init